HOLLY ROGERS: Open Payments
NPI 1881086148 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 71 payments from 18 companies in 2025. Trend: 2023 $597 · 2024 $883 · 2025 $1,130
Food & beverage: $1,085Education: $45
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $207 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $143 |
| Actelion Pharmaceuticals US, Inc. | 4 | $86 |
| GENZYME CORPORATION | 5 | $83 |
| Regeneron Healthcare Solutions, Inc. | 5 | $75 |
| CSL Behring | 3 | $75 |
| Stryker Corporation | 2 | $69 |
| Insmed, Inc. | 2 | $68 |
| United Therapeutics Corporation | 3 | $66 |
| Grifols USA, LLC | 3 | $53 |
Products named: DUPIXENT, NUCALA, Kcentra, OFEV, Tyvaso, TEZSPIRE, Prolastin-C Liquid, FLOWSAVER.
Industry payments across AR — which companies pay providers there.
